Recurrent acromegaly: a systematic review on therapeutic approaches

• Published in: BMC endocrine disorders Vol. 24; no. 1; p. 13
• Main Authors: Maroufi, Seyed Farzad, Sabahi, Mohammadmahdi, Aarabi, Seyed Sahab, Samadian, Mohammad, Dabecco, Rocco, Adada, Badih, Arce, Karla M, Borghei-Razavi, Hamid
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 26.01.2024; BioMed Central; BMC
• Subjects: Acromegaly; Acromegaly - drug therapy; Acromegaly, Radiotherapy, Medical therapy, Trans-sphenoidal surgery, Recurrence; Care and treatment; Health aspects; Humans; Insulin-like growth factors; Medical research; Medicine, Experimental; Mortality; Patients; Performance evaluation; Radiation therapy; Radiotherapy; Remission; Remission (Medicine); Reoperation; Statistical analysis; Surgery; Surgical outcomes; Systematic review; Treatment Outcome; Tumors; Acromegaly, Radiotherapy, Medical therapy, Trans-sphenoidal surgery, Recurrence
• ISSN: 1472-6823; 1472-6823
• DOI: 10.1186/s12902-023-01533-w

Management of recurrent acromegaly is challenging for both neurosurgeons and endocrinologists. Several treatment options including repeat surgery, medical therapy, and radiation are offered for such patients. The efficacy of these modalities for the treatment of recurrence has not been studied previously in the literature. In this study, we aim to systematically review the existing cases of recurrence and come to a conclusion regarding the appropriate treatment in such cases. A systematic review was performed through PubMed, Scopus, Web of Science, and Cochrane database to identify studies reporting the treatment outcome of recurrent acromegaly patients. Using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, the included studies were reviewed for primary and secondary treatment, complications, and outcomes of the secondary treatment. The systematic review retrieved 23 records with 95 cases of recurrent acromegaly. The mean time of recurrence was 4.16 years after the initial treatment. The most common primary treatment was surgery followed by radiotherapy. The remission rate was significantly higher in medical and radiotherapy compared to surgical treatment. In cases of recurrent acromegaly, the patient may benefit more from radiotherapy and medical therapy compared to surgery. As the quality of evidence is low on this matter feature studies specifically designed for recurrent patients are needed.